Cytogenetically masked CBFB-MYH11 fusion and concomitant TP53 deletion in a case of acute myeloid leukemia with a complex karyotype

Leuk Lymphoma. 2020 Jul;61(7):1772-1774. doi: 10.1080/10428194.2020.1742905. Epub 2020 Mar 29.

Benoît Ducourneau^{1

2}, Laurène Fenwarth^{1

3}, Nicolas Duployez^{1

3}, Juliette Lambert⁴, Stéphanie Struski⁵, Isabelle Luquet⁵, Agnès Daudignon⁶, Nathalie Helevaut^{1

3}, Philippe Ruminy⁷, Claude Preudhomme^{1

3}, Christine Terre^{8

9}

¹ Chu de Lille, Laboratory of Hematology, Lille, France.
² Laboratory of Hematology, Centre Hospitalier de Valenciennes, Valenciennes, France.
³ University of Lille, CNRS, INSERM, Lille, France.
⁴ Department of Hematology, Centre Hospitalier de Versailles, Le Chesnay, France.
⁵ IUCT Oncopole, Laboratory of Hematology, Toulouse, France.
⁶ Department of Medical Genetics, Chu de Lille, Lille, France.
⁷ Institute for Research and Innovation in Biomedicine, Centre Henri Becquerel and Rouen University, Rouen, France.
⁸ Laboratory of Hematology, Centre Hospitalier deVersailles, Le Chesnay, France.
⁹ Laboratory of Cytogenetics, Centre Hospitalier deVersailles, Le Chesnay, France.

No abstract available

Publication types